SubHero Banner
Text

June 2019

Core topics in this month’s edition include:

  • Kanjinti (trastuzumab-anns) - new biosimilar approval
  • Vyleesi (bremelanotide) - new drug approval
  • Zirabev (bevacizumab-bvzr) - new biosimilar approval

Download PDF

Text